| Stage | AIN | % of rev | ALGN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $350M | 100.00% | $1.1B | 100.00% | ALGN ×3.02 |
| Gross profit | $140M | 40.16% | $757M | 71.71% | ALGN +31.6pp |
| Operating income | $59M | 16.99% | $154M | 14.58% | AIN +2.4pp |
| Pre-tax income | $56M | 15.96% | $149M | 14.08% | AIN +1.9pp |
| Net income | $42M | 11.98% | $108M | 10.25% | AIN +1.7pp |
| Stage | AIN | ALGN | Gap · A − B |
|---|---|---|---|
| Revenue | $350M100.00% | $1.1B100.00% | ALGN ×3.02 |
| Gross profit | 40.16%$140M | 71.71%$757M | ALGN +31.6pp |
| Operating income | 16.99%$59M | 14.58%$154M | AIN +2.4pp |
| Pre-tax income | 15.96%$56M | 14.08%$149M | AIN +1.9pp |
| Net income |
| 11.98%$42M |
| 10.25%$108M |
| AIN +1.7pp |
No disclosed counterparties: ALGN.
None